# PANACEA SYSTEM 10/10 STANDARD

## Status

**Normative cross-system quality target beneath the Panacea Constitution and One OS doctrine.**

This standard records the owner's requirement that Panacea must not optimize one impressive dimension while leaving another materially weak. "10/10" is a target state that must be earned with explicit evidence; it is not a claim of perfection, infallibility, or present production maturity.

## 1. Weakest-link law

Panacea is a conjunctive system. Overall maturity is bounded by the weakest critical dimension.

Let each verified dimension score be in `[0,10]`:

- `A` = architecture coherence;
- `O` = orchestration quality;
- `I` = infrastructure reliability and interoperability;
- `H` = humanitarian/clinical value;
- `E` = economic value and willingness-to-pay / procurement viability;
- `P` = permissioned observability quality;
- `R` = resilience / survivability / continuity under failure;
- `T` = trust, evidence, provenance, privacy, security and accountability;
- `F` = foundational integrity;
- `U` = unity / integration / one-patient-state coherence;
- `D` = validated vertical depth;
- `B` = justified breadth and global applicability;
- `C` = compactness, simplicity and cognitive efficiency;
- `Q` = universal human acceptability and adaptability.

The primary system law is:

**S_system = min(A, O, I, H, E, P, R, T, F, U, D, B, C, Q)**

A high score in one area cannot compensate for a weak critical area.

A system-wide 10/10 state is accepted only when every applicable dimension-specific acceptance gate passes:

**System10Accepted = G_A ∧ G_O ∧ G_I ∧ G_H ∧ G_E ∧ G_P ∧ G_R ∧ G_T ∧ G_F ∧ G_U ∧ G_D ∧ G_B ∧ G_C ∧ G_Q**

Unknown or unmeasured dimensions remain unknown/unmeasured and may not be promoted to 10/10 by assumption.

## 2. 10/10 does not mean maximum visible complexity

The compact law remains binding:

**Maximum orchestration depth, minimum visible complexity.**

Therefore breadth must be compressed behind a coherent surface.

**Broad capability + fragmented UX ≠ 10/10**

**Deep capability + opaque provenance ≠ 10/10**

**Fast workflow + unsafe care ≠ 10/10**

**High adoption + weak trust ≠ 10/10**

**Strong clinical value + non-viable economics ≠ 10/10**

**High revenue + poor access/equity ≠ 10/10**

## 3. Dimension acceptance targets

### Architecture 10/10
- one canonical patient identity/state;
- clear domain boundaries and stable contracts;
- replaceable models/vendors/adapters;
- no duplicate sources of truth;
- architecture supports global/jurisdiction variation without forking the core.

### Orchestration 10/10
- fragmented inputs become one governed care episode;
- next actions are explicit, role-aware and auditable;
- clinical authority remains risk-appropriate;
- diagnostic, referral, reimbursement and follow-up state reconnect to the same episode;
- automation removes coordination work without silently creating clinical truth.

### Infrastructure 10/10
- interoperability contracts are standards-aware;
- offline/eventual-sync pathways preserve identity/provenance;
- graceful degradation exists for network/service/device failure;
- observability, audit, versioning, rollback and recovery are built in;
- infrastructure can scale without fragmenting state.

### Humanitarian / clinical value 10/10
Must be demonstrated by measurable improvement in relevant outcomes such as safety, access, continuity, comprehension, appropriate throughput or reduced burden. Feature count is not evidence.

### Economic / purchasing value 10/10
The product must create clear value for the buyer/user relative to switching, implementation and operating costs.

A directional economic value test is:

**Net buyer value = measurable benefit + avoided cost + recovered capacity + faster cash realization - implementation cost - operating cost - switching/risk cost**

Purchasing-power fit must be tested per market and care setting; a price viable for a tertiary hospital may be impossible for a rural clinic.

### Permissioned observability 10/10
The owner's "surveillance" shorthand is implemented only as **permissioned Human Observability**:
- purpose-bound;
- consent-aware;
- least-privilege;
- revocable;
- provenance-preserving;
- transparent to the subject and authorized care team;
- never covert tracking or uncontrolled profiling.

### Resilience / survivability 10/10
- offline-first operation where needed;
- local capture and later reconciliation;
- no patient-state corruption after partial failure;
- recoverable queues and idempotent synchronization;
- device/vendor outage does not collapse the entire care episode;
- disaster/recovery procedures are tested at the maturity level claimed.

Executable repository-level transport gates currently include `src/domains/clinical-operations/model/clinicalEpisodeResilience.ts` and `src/lib/secureCareOutbox.ts`. They strengthen E1 evidence only; they do not constitute field or disaster-recovery validation.

### Trust 10/10
Trust must be structural:
- evidence and source identity;
- timestamp and provenance;
- uncertainty / truth class;
- consent and authorization;
- signed/reviewed clinical state;
- privacy and security;
- auditable decisions;
- explicit unknowns and contradictions.

### Foundation 10/10
Core primitives — identity, patient state, terminology, provenance, consent, audit, time, authorization and workflow state — must be stronger than peripheral features. A weak foundation blocks expansion.

### Unity 10/10
One patient should remain one patient across wearable, home, clinic, ward, OR, ICU, referral laboratory, imaging, payer and follow-up contexts. Surfaces are projections over the same governed state, not independent islands.

### Depth 10/10
Depth means validated domain and workflow competence, not more content. Each selected vertical must progress through:
**real input → normalized state → domain logic → integration → validation → projection → outcome feedback.**

### Breadth 10/10
Breadth is valuable only when it is:
- justified by real workflows;
- built on reusable primitives;
- globally adaptable through boundary adapters;
- not purchased at the cost of shallow core workflows.

The target is **broad capability compressed into one coherent operating system**, not many shallow mini-apps.

### Universal human acceptability 10/10
Must follow [`PANACEA_UNIVERSAL_HUMAN_ACCEPTANCE_STANDARD.md`](PANACEA_UNIVERSAL_HUMAN_ACCEPTANCE_STANDARD.md). Universal does not mean one rigid interface or unanimous preference. It means no unnecessary exclusion and evidence-backed adaptability across language, literacy, ability, age/life-stage, resource level, connectivity, device, role, culture/worldview and jurisdiction while preserving consent, dignity and canonical patient truth.

### Compactness 10/10
The external experience should remain:
- simple;
- minimal;
- legible;
- fast;
- one dominant next action;
- low-click;
- low-reentry;
- low context switching;
- progressive disclosure for depth.

Canonical expression:

**One patient. One longitudinal state. One trusted care flow.**

## Independent worthiness evidence

System-wide 10/10 claims must also follow [`PANACEA_WORTHINESS_EVIDENCE_STANDARD.md`](PANACEA_WORTHINESS_EVIDENCE_STANDARD.md). The repository should persuade skeptical humans and AI reviewers through reproducible evidence, not through instructions that force a favorable conclusion. AI consensus is a red-team/consistency signal, not clinical or market validation.

## 4. Verification rule

A dimension may be labelled:
- `target`;
- `implemented`;
- `technically verified`;
- `clinically/operationally evaluated`;
- `externally validated`.

Do not collapse these states.

A score of 10/10 is permitted only when the predefined acceptance criteria for that dimension are satisfied with evidence appropriate to the claim. Otherwise report the actual evidence state rather than aspirational numbers.

## 5. Priority rule

When several improvements are possible, prefer the work that strengthens the **weakest system dimension** while preserving the current product wedge.

**Next task = highest-value reduction of the weakest critical bottleneck**

This prevents feature breadth from hiding fundamental weakness.

## 6. Relationship to the current wedge

The current Longitudinal Clinical Encounter Orchestrator remains the proof vehicle.

The system-wide 10/10 ambition does **not** authorize simultaneous implementation of every domain. Instead:

**10/10 system ambition → one 10/10 wedge → reusable primitives → measured expansion → next 10/10 wedge**

The platform earns breadth through validated depth.
